IL144439A0 - Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and copper salt - Google Patents

Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and copper salt

Info

Publication number
IL144439A0
IL144439A0 IL14443900A IL14443900A IL144439A0 IL 144439 A0 IL144439 A0 IL 144439A0 IL 14443900 A IL14443900 A IL 14443900A IL 14443900 A IL14443900 A IL 14443900A IL 144439 A0 IL144439 A0 IL 144439A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical composition
copper salt
containing sulfur
mustard seeds
Prior art date
Application number
IL14443900A
Other languages
English (en)
Inventor
Norbert A Gschwend
Norbert Gschwend
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL144439A0 publication Critical patent/IL144439A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14443900A 1999-01-20 2000-01-19 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and copper salt IL144439A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99100923A EP0983766A1 (de) 1999-01-20 1999-01-20 Pharmazeutische Zusammensetzung zur Behandlung von rheumatischen Syndromen enthaltend Schwefel, Senfsamen und einen Kupfersalz
PCT/CH2000/000027 WO2000043021A1 (de) 1999-01-20 2000-01-19 Pharmazeutische zusammensetzung zur behandlung von rheumatischen syndromen enthaltend schwefel, senfsamen und einen kupfersalz

Publications (1)

Publication Number Publication Date
IL144439A0 true IL144439A0 (en) 2002-05-23

Family

ID=8237372

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14443900A IL144439A0 (en) 1999-01-20 2000-01-19 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and copper salt

Country Status (10)

Country Link
EP (1) EP0983766A1 (xx)
JP (1) JP2002535280A (xx)
KR (1) KR20010113657A (xx)
CN (1) CN1337882A (xx)
AU (1) AU747416B2 (xx)
BR (1) BR0007641A (xx)
CA (1) CA2358474A1 (xx)
IL (1) IL144439A0 (xx)
NO (1) NO20013555L (xx)
WO (1) WO2000043021A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007257286B2 (en) 2006-06-02 2013-02-21 Natural Ma Inc. Use of Micron-sized sulphur for the Prevention and Treatment of Pathogenic Disorders in Humans and Animals
CN104225112B (zh) * 2013-06-13 2017-12-22 陈卫衡 一种治疗骨性关节炎的中药组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8128911U1 (de) * 1981-10-02 1982-06-16 Energy-Pak Europe Ltd., 9490 Vaduz Magnetpflaster
CH660971A5 (en) * 1983-07-07 1987-06-30 Schwab F A & Co Therapeutic composition
DE3433076A1 (de) * 1984-09-08 1986-03-20 Alfred Dipl.-Biochem. 7400 Tübingen Gärtner Verfahren zur isolierung und anwendung von kupfer-metallothioneinen zur antirheumatischen therapie
CN1032622C (zh) * 1993-01-19 1996-08-28 王来运 伸筋活络丹液
CN1099970A (zh) * 1993-09-11 1995-03-15 宋建祥 中医药保健衣着用品及其生产方法
CN1130074A (zh) * 1995-03-01 1996-09-04 李凤欣 慢性风湿症骨质增生病外敷药
GB2315674B (en) * 1996-08-01 2000-06-21 Richard John Cleeve Mammalian foodstuff
CN1191729A (zh) * 1997-02-20 1998-09-02 李国荣 痛贴
CN1164410A (zh) * 1997-04-22 1997-11-12 高贵 治疗静脉炎的外用制剂
CN1049353C (zh) * 1997-07-30 2000-02-16 张巨文 一种治疗风湿、类风湿病的中药制剂及其制备方法
CN1057001C (zh) * 1997-09-10 2000-10-04 沈春楼 一种治疗类风湿的纯中药胶囊

Also Published As

Publication number Publication date
EP0983766A1 (de) 2000-03-08
NO20013555L (no) 2001-09-10
AU1961600A (en) 2000-08-07
NO20013555D0 (no) 2001-07-18
KR20010113657A (ko) 2001-12-28
BR0007641A (pt) 2001-10-16
WO2000043021A1 (de) 2000-07-27
CA2358474A1 (en) 2000-07-27
JP2002535280A (ja) 2002-10-22
CN1337882A (zh) 2002-02-27
AU747416B2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
HUP0200155A3 (en) Thioamide derivatives, pharmaceutical compositions containing them and their use
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HK1046240A1 (en) Pharmaceutical compositions for the treatment of insulin resistance
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0400451A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
IL146703A0 (en) Dietary of pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
PL351134A1 (en) Compositions for treatment of disorders of the oesophagus
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
IL140525A0 (en) 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
HUP0300295A3 (en) Substituted benzamide derivatives, pharmaceutical compositions containing them and their use
IL144439A0 (en) Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and copper salt